trough valuat number de-risk
messag result skew neg better
expect offer bright spot satisfi bull strong margin
expans na importantli make progress margin enhanc
initi europ mask signific de-lever given sale
pressur macro tough compar fewer sell day look ahead weaker
europ macro remain risk valuat limit downsid yield
think risk/reward skew posit next month number de-risk
compar easier restructur benefit like support stronger margin pt
goe roll estim
bull like
driven primarili bp gm expans expans strongest sinc
notabl exclud self-servic busi impact declin scrap
metal price gross margin ebitda margin rest na segment
bp bp respect believ strong na margin perform
despit weaker top-lin reflect progress cost structur optim
effort region look ahead manag believ runway
cost effici opportun support continu margin expans
impress gener deliv million free cash flow
repres y/i growth record high compani follow strong cash
gener nearli hit full year guidanc quarter growth
driven three segment though na europ post signific gain
importantli recent sharp improv cash gener reflect increas focu
work capit manag especi compens tie earlier
year look ahead despit strong rais guidanc million
million given headwind lower earn outlook work capit
season increment restructur cost said sens guidanc still
leav room upsid note mid-point trade attract
restructur effort underway take aggress action improv
margin announc restructur result million
annual save driven facil closur headcount reduct manag
also announc major european optim effort use consult strateg
plan execut plan host investor confer call septemb
discuss detail includ time cost benefit importantli believ
manag go reiter confid achiev double-digit europ
margin like push timelin believ alreadi expect
investor
capit alloc remain posit stronger free cash flow gener year
alreadi led greater return cash sharehold includ million worth
buyback million debt paydown last two quarter
bear like
weaker organ growth across board outlook better report
declin total part servic organ growth street expect
first quarter neg organ growth compani histori weak
driven segment na europ specialti na
page analyst certif import disclosur
weak driven declin collis claim volum mild weather moder
mile driven highlight lap tough comparison ly
trend actual acceler sequenti two year stack basi na also impact
continu under-perform aviat glass segment organ growth
core part distribut busi respect europ also
lap tough comparison ly also deal one less sell day
same-day basi encouragingli europ organ growth same-day also
acceler sequenti two year stack manag note weak
europ driven macro headwind across much contin brexit uk
recess itali slow growth germani led greater consum
deferr impact volum trade down impact ticket mild winter europ
also factor importantli significantli outperform peer
report declin organ growth support view soft top-
line result europ indic share loss execut issu look
ahead eas compar flat two year stack would impli acceler
posit organ growth come quarter na europ also benefit
extra sell day support view near-term top-lin outlook
posit europ macro like remain headwind near-term
europ margin head wrong direct europ segment ebitda margin
declin bp driven primarili sg de-lever gm stabl
weak disappoint light rel easi year-earli comparison
bp ly note neg organ growth exacerb one less sell day
drove signific fix cost de-lever primari reason compress
cost associ compani acquisit integr effort specif
erp implement result bp margin headwind posit
side de-lever similar last year despit bp lower organ growth
y/i also significantli less peer europ segment
think reflect compani progress cost control initi look
expect improv europ margin organ growth like turn posit easier
compar calendar benefit recent restructur effort also
tailwind like ramp
ep in-lin report ep in-lin street
estim sale billion y/i street billion
us billion gross margin expand bp y/i
estim adj sg sale delev bp compar
estim net adj oper margin contract bp y/i
estim neg scrap rate headwind
quarter fx also neg impact ep
lower estim lower ep estim
 reflect weaker organ growth outlook similarli
ebitda goe million million million million larg
flow result
valuat current trade ntm price-to-earnings ntm ebitda
discount year averag believ modest discount appropri given
macro risk europ slower organ growth recent combin improv
margin free cash flow near-to-medium term like result multipl
expans current near-trough level accordingli price target assum
price-to-earnings multipl ep estim vs prior
ebitda multipl million ebitda estim vs million
prior multipl repres discount averag
risk key downsid risk valuat thesi includ weaker european
macro backdrop includ hard brexit execut risk particularli europ
compani embark integr multipl larg scale acquisit continu macro
cost headwind freight wage scrap north america
page analyst certif import disclosur
page analyst certif import disclosur
amount million except per gross depreci expens ex oper incom oper incom ebitda ebitda interest incom tax expens loss incom loss cont op discontinu oper net incom net incom share ep ep adjust analysisgross oper incom incom margin incom incom incom per share compani report guggenheim secur llc estim auto part retail distributor
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic corpor
next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori corpor
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
